Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

Global Fibromyalgia Pipeline Report 2016 - Review of 7 Companies & Drug Profiles - Research and Markets

Research and Markets
Posted on: 31 Aug 16

Research and Markets has announced the addition of the "Fibromyalgia - Pipeline Review, H2 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for Fibromyalgia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Fibromyalgia and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Fibromyalgia Overview
  3. Therapeutics Development
  4. Pipeline Products for Fibromyalgia - Overview
  5. Pipeline Products for Fibromyalgia - Comparative Analysis
  6. Fibromyalgia - Therapeutics under Development by Companies
  7. Fibromyalgia - Therapeutics under Investigation by Universities/Institutes
  8. Fibromyalgia Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Fibromyalgia - Products under Development by Companies
  13. Fibromyalgia - Products under Investigation by Universities/Institutes
  14. Fibromyalgia - Companies Involved in Therapeutics Development
  • Astellas Pharma Inc.
  • Daiichi Sankyo Company, Limited
  • Merck & Co., Inc.
  • SWITCH Biotech LLC
  • Theravance Biopharma, Inc.
  • Tonix Pharmaceuticals Holding Corp.
  • Zynerba Pharmaceuticals, Inc.

For more information about this report visit

Related Topics: Immune Disorders Drugs, Musculoskeletal Disorders Drugs

View source version on

Business Wire

Last updated on: 31/08/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.